电子邮件 | jgo***@***.com | 获取Email |
---|
电子邮件 | jgo***@***.com | 获取Email |
---|
Adjacent to a lumbar discectomy, the Barricaid® device is designed to close large defects in the annulus, which often lead to disc reherniation and/or disc collapse. Barricaid is a permanent implant with two components - a titanium bone anchor and a flexible polymer barrier. The barrier is designed to prevent reherniation by physically blocking the annulus at the post-surgery defect. The anchor component is comprised of titanium alloy that is placed into either the caudal or cranial-adjacent vertebral body to secure the device in position. The Barricaid has been studied in a definitive – level 1B evidence - randomized superiority trial with over 550 patients enrolled (clinicaltrials.gov NCT01283438). The study focuses on patient at highest risk of reherniation and reoperation, enrolling only those patients with large defects (width >5 mm). The co-primary endpoints of reherniation and an 8-point composite of safety and effectiveness are evaluated at 2 years, with a parallel cost effectiveness analysis. Treated patients were found superior on both endpoints, with significantly lower rates of symptomatic recurrences (12% vs. 25%, p<0.001), index-level reoperations (9% vs. 16%, p=0.01), and device or procedure related serious adverse events (SAEs) (7% vs. 17%, p=0.001). Through two years, a total of 29 reoperations were performed in Barricaid subjects in comparison to 61 procedures in Controls. Study results are published in The Spine Journal, May 2018. Barricaid is FDA-Approved For full risk/benefit, see: www.barricaid.com/instructions-for-use
公司 | Intrinsic Therapeutics, Inc |
---|---|
职位 | Territory Manager |
地点 | United States |
http://www.linkedin.com/in/john-godwin-46434312 | |
部门 | master_sales |
头衔 | Maternal Health Sales Manager |
Intrinsic Therapeutics, Inc Territory Manager
2023-05-01 -
Alydia Health Maternal Health Sales Manager
2021-10-01 - 2022-03-01
Organon Maternal Health Sales Manager
2021-10-01 - 2023-05-01
Strategic Account Manager
2020-01-01 - 2021-10-01
Territory Manager
2014-12-01 - 2020-01-01
John Godwin 在 Intrinsic Therapeutics, Inc 担任 Maternal Health Sales Manager
John Godwin 在 Intrinsic Therapeutics, Inc 的职位是 Maternal Health Sales Manager
John Godwin 的电子邮件地址是 jgo***@***.com
John Godwin 的电话号码是 -
John Godwin 的公司电话号码是 +178****
John Godwin 在 medical devices 工作。
John Godwin 的一些同事包括Marti Concannon、Ben Kelly、Aurora Armstrong、Kelsey Miller-TorchiaMatt Starnes、。
John Godwin联系方式: 电子邮件地址:jgo***@***.com 电话号码:-
John Godwin 的个人领英是:http://www.linkedin.com/in/john-godwin-46434312
John Godwin 的办公地点:30 commerce way, woburn, massachusetts, united states, 01801
Top-ranked on G2 Crowd
全球B2B企业库 海关贸易数据 展会采购数据
全球B2B企业库
海关贸易数据
展销采购数据
Top-ranked on G2 Crowd